Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,359 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07349797Recruiting
Transdermal GFR system to check kidney function in heart failure
This trial tests a sensor placed on the skin to measure kidney function in adults with heart failure. It may help understand how well the kidneys are working without repeated blood draws.
New York, New YorkAges 18 years+ - NCT07620964Recruiting
Testing a journal app to track media use for teens
This study asks teenagers to use an interactive journal app to track how much time they spend on phones, tablets, social media, and other screens. Researchers want to understand if the app helps teens become more aware of their media habits.
Madison, WisconsinAges 13–18 - NCT05609630RecruitingPhase 3
Testing two medicines for active systemic juvenile arthritis
This Phase 3 trial studies how well upadacitinib (a pill) and tocilizumab (a shot/IV medicine) improve symptoms and inflammation in children with active systemic juvenile idiopathic arthritis (sJIA). It also looks at side effects and how these medicines move through the body.
Phoenix, ArizonaAges 1–17 - NCT07365241RecruitingPhase 3
Study of ABBV-706 vs standard care for advanced small cell lung cancer
This trial tests a new drug called ABBV-706 against standard treatments (topotecan, lurbinectedin, or amrubicin) for people with small cell lung cancer that has come back or stopped responding to previous therapies. The goal is to see if ABBV-706 works better at controlling the cancer.
Birmingham, AlabamaAges 18 years+ - NCT07223203RecruitingPhase 3
Study of nucresiran for hereditary nerve condition (hATTR-PN)
This trial tests a new medicine called nucresiran for people with a rare genetic nerve condition (hATTR-PN). The goal is to see if it can slow down or improve nerve damage.
Aurora, ColoradoAges 18–85 - NCT07210515RecruitingPhase 3
Testing Ambros Therapy for Early CRPS
This trial tests if an intravenous medicine called AMBTX-01 (neridronate) can help people with early-stage Complex Regional Pain Syndrome (CRPS) type 1. It focuses on those whose affected limb feels warm, looks red, and is swollen.
Phoenix, ArizonaAges 18 years+ - NCT07760974Recruiting
Comparing two surgical guides for placing front tooth implants
This study compares two types of 3D-printed guides used during dental implant placement in the front of the mouth. The goal is to see if a new guide (SocketFit) is more accurate than the standard one, which could lead to better implant positioning and outcomes.
Tanta, Gharbia GovernorateAges 18–35 - NCT07719608Recruiting
MySalvia system for resistant migraine
This trial tests a device called MySalvia that is implanted in the head to reduce migraine attacks. It is for people whose migraines have not improved with at least three different preventive treatments.
Newnan, GeorgiaAges 22–84 - NCT07764328Recruiting
Supplement for hormone balance in women with PCOS
This trial tests a dietary supplement designed to improve hormone balance in women with PCOS or PCOS-like symptoms. It may help regulate menstrual cycles and reduce signs like acne or excess hair growth.
Los Angeles, CaliforniaAges 18–40 - NCT07308834RecruitingPhase 1/Phase 2
Injection for knee osteoarthritis pain
This study tests an injection called CX-011 for people with knee osteoarthritis who still have moderate to severe pain despite trying other treatments. The goal is to see if the injection can reduce pain and improve knee function.
Los Angeles, CaliforniaAges 40–75 - NCT07764250Recruiting
Standing with distraction: balance and memory training for older adults
This study compares two types of balance and mobility training for older adults with mild to moderate memory or thinking problems. The training involves doing mental tasks while standing or walking, which may help improve both physical and cognitive function.
Islamabad, CapitalAges 55–90 - NCT07570823RecruitingPhase 3
SCTB35 Plus Chemotherapy for Relapsed Lymphoma
This study tests a new drug called SCTB35 combined with two common chemotherapy drugs (gemcitabine and oxaliplatin) for patients with diffuse large B-cell lymphoma that has come back or stopped responding to previous treatment. The goal is to see if this combination is safe and helps shrink the cancer.
BeijingAges 18–80 - NCT07762287RecruitingPhase 1
How two forms of elinzanetant are processed in healthy women
This study looks at how the body handles two different forms of a drug called elinzanetant in healthy women. It helps doctors understand the drug's effects and may guide future treatment options.
Mount Royal, QuebecAges 18–65 - NCT07562022RecruitingPhase 3
SCTB35 Plus Lenalidomide for Resistant Follicular Lymphoma
This trial tests a new drug called SCTB35 combined with lenalidomide (a known cancer drug) in people whose follicular lymphoma (a type of blood cancer) has stopped responding to or come back after previous treatments. The combination may help shrink tumors and improve survival.
Beijing, Beijing MunicipalityAges 18–80 - NCT07762911Recruiting
MRI-based prostate cancer screening follow-up
This study is a follow-up for men already in the VISIONING prostate cancer screening program. It uses MRI scans to check for prostate cancer over 5 more years, helping catch any changes early.
Basel, Canton of Basel-CityAges 50 years+ - NCT07763158Recruiting
Treatment for severe knee pain using artery embolization
This study tests a procedure that blocks tiny arteries in the knee to reduce pain from severe arthritis. It is for people who cannot have knee replacement surgery because of other health issues.
Jeddah, Mecca RegionAges 18 years+ - NCT07763197Recruiting
Sample collection for bladder cancer research
This study is collecting blood, urine, and tissue samples from people with high-risk non-muscle invasive bladder cancer to help develop better tests for tracking the disease. By participating, you might help improve future monitoring and treatment decisions.
Austin, TexasAges 18 years+ - NCT06359041RecruitingPhase 1/Phase 2
CABA-201 cell therapy for generalized myasthenia gravis
This trial tests a new cell therapy called CABA-201 for people with generalized myasthenia gravis. It aims to reset the immune system to reduce muscle weakness and improve daily functioning.
Orange, CaliforniaAges 18–70 - NCT07763990Recruiting
Injectable hyaluronic acid for facial volume and lines
This study tests a new injectable filler made of hyaluronic acid (a natural substance that adds volume) to improve the look of lips, smile lines, or cheeks. If you qualify, you'll receive the treatment and be monitored for safety and results.
Tel AvivAges 21 years+ - NCT07482787RecruitingPhase 3
Study of SD-101 for epidermolysis bullosa in children
This trial tests a new medicine called SD-101 for children with epidermolysis bullosa (EB), a condition that causes fragile skin and blistering. It aims to see if SD-101 can help heal wounds and improve quality of life.
Rancho Santa Margarita, CaliforniaAges 4 weeks–12 years - NCT07762651Enrolling by invitation
Tooth-colored fillings for back teeth compared
This study compares two types of tooth-colored filling materials for back teeth. It aims to see which one lasts longer and works better.
Tanta, TantaAges 25–40 - NCT07273773Recruiting
Evaluating a new inflatable penile implant for erectile dysfunction
This trial tests a device called the Infla10®, an inflatable penile implant for men with erectile dysfunction. The goal is to see how well it works and how safe it is.
Coral Gables, FloridaAges 22 years+ - NCT07670416RecruitingPhase 3
A study of enicepatide for people with obesity or overweight
This trial tests if enicepatide can help people with obesity or overweight lose weight, including those with or without type 2 diabetes. It aims to see if the drug is safe and effective.
Zhengzhou, HenanAges 18 years+ - NCT06612268RecruitingPhase 3
Testing etavopivat for sickle cell disease
This study tests an experimental pill called etavopivat for people with sickle cell disease who have had some pain crises in the past year. The goal is to see if it reduces these crisis episodes.
Birmingham, AlabamaAges 12 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,359 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.